Fortis Healthcare share news, announcements and annual reports

NSE: FORTISBSE: 532843Healthcare ServicesMid Cap

Fortis Healthcare Limited · Formerly Fortis Healthcare (India) · Face value ₹10 · Listed May 2007

₹768.15₹13.25 (1.76%)BSE ₹769.80

Share price at the NSE close on 30 Oct 2026. Previous close ₹754.90.

30 Oct: open ₹754.90, high ₹768.15, low ₹745.00

52-week range of traded prices to 30 Oct 2026

₹704.95Low, 23 Oct 2026₹1,057.45High, 30 Oct 2025

Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar

Market cap: ₹57,992 Cr156th largest listed
P/E: 55.34
P/B: 5.86
Dividend yield: 0.13%
ROE: 11.1%
ROCE: 12.7%
Debt to equity: 0.28
Volume, NSE: 14,56,10356.9% delivered

Fortis Healthcare share news and announcements

1,301 announcements, routine notices left out, newest first. Page 17 of 27.

Aug 2016
Jul 2016
- 27 Jul · Board meeting
  Inter alia, consider and approve the un-audited financial results for the quarter ended June 30, 2016.
- 20 Jul · News Verification
  Exchange has sought clarification from Fortis Healthcare Limited with respect to recent news item captioned "Fortis set to demerge SRL Diagnostic in a separate entity in next 2-3 weeks". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Fortis Healthcare Limited has submitted their response.
- 20 Jul · News Verification
  Exchange has sought clarification from Fortis Healthcare Limited, with respect to recent news item captioned "Fortis set to demerge SRL Diagnostic in a separate entity in next 2-3 weeks". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Jun 2016
- 10 Jun · Updates
  One of the subsidiaries of the Company viz. Escort Heart Institute & Research Centre Limited (EHIRCL) has informed us that in a long disputed case pertaining to the period 1984-2007 , it has today received an order from The Directorate General of Health Services (DHS) for the deposit of an amount of Rs. 503, 36, 52, 824/- (Rupees Five Hundred & Three Crores, Thirty Six Lac, Fifty- Two Thousand Eight Hundred and Twenty Four only) towards recovery of unwarranted profit made by it for alleged non-compliance of the conditions of allotment / lease of land since its allotment in 1982. EHIRCL has further informed that the impugned order in its view is legally flawed and untenable. The management will challenge the same in the Hon ble High Court of Delhi or such relevant authority to seek suitable legal remedies available to it under law.
May 2016
Mar 2016
- 23 Mar · Management
  Board of Directors at its meeting held March 23, 2016, accepted the resignation of Mr. Udai Dhawan, a Non-Executive Director of the Company with immediate effect.
- 21 Mar · Regulation 44(3) of SEBI (LODR), Reg., 2015
  Voting results of Postal Ballot as per the format prescribed under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- 18 Mar · Updates
  One of our stepdown subsidiary company viz Fortis Cancer Care Limited has informed us that it has increased its shareholding in Lalitha Healthcare Private Limited (Lalitha) by 98972 equity shares (i.e. 12.2% of total share capital of Lalitha) of Rs. 10 each.
- 15 Mar · Disclosure
  Allotment of 6,200 Equity Shares of the Company
Feb 2016
- 19 Feb · News Verification
  Exchange has sought clarification from Fortis Healthcare Limited, with respect to recent news item captioned "Baring, Capital & Bain in Race to Buy SRL Diagnostics". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Fortis Healthcare Limited has submitted their response.
- 19 Feb · News Verification
  Exchange has sought clarification from Fortis Healthcare Limited, with respect to recent news item captioned "Baring, Capital & Bain in Race to Buy SRL Diagnostics" . In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
- 4 Feb · Board meeting
  Outcome of Board of Directors of the Company held on February 04, 2016 along with the press release.
- 4 Feb · Results
  Consolidated financial results along with the Limited Review Report for the period ended December 31, 2015.
- 3 Feb · Updates
  This is in continuation of Company's earlier announcement dated November 26, 2015 on Agreement to acquire of Religare Health Trust Trustee Manager Pte Ltd (RHTTM). The Company has now informed to the Exchange that the said transaction has been completed and one of our step down subsidiaries viz. Stellant Capital Advisory Services Private Limited (Stellant) has acquired 100% of the issued shares of Religare Health Trust Trustee Manager Pte Ltd (a company incorporated in Singapore that acts as Trustee Manager to Religare Health Trust (RHT), of which the Company is the controlling unitholder), at a consideration of USD 14.9 Million.
Jan 2016
- 28 Jan · Board meeting
  To inter-alia, approve the Un-Audited Financial Results of the Company, for the Quarter and nine months ended on December 31, 2015.
Dec 2015
- 9 Dec · Updates
  Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as Regulations), the Company has adopted the 'Policy on Determination of Materiality of Event/ Information'.Further, pursuant to the provisions of the said Regulations, the Company has authorized Mr. Bhavdeep Singh- Chief Executive Officer, Mr. Gagandeep Singh Bedi- Chief Financial Officer and Mr. Rahul Ranjan- Company Secretary, Key Managerial Personnel (KMPs) of the Company for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s).
- 4 Dec · Business
  Nomination and Remuneration Committee of the Company has approved allotment of 10,000 equity shares of Rs. 10/- each to the grantee upon exercise of vested stock options.
Nov 2015
Oct 2015
Sep 2015
- 28 Sep · Board meeting
  Board of Directors of the Company ,on September 28, 2015, approved the acceptance of ROFR Notice issued to the Company by Sabre Partners Trust , Spring Healthcare (P) Limited and Spring Healthcare India Trust, (Investors). Under the ROFR Notice, the Investors had offered to transfer their complete shareholding in SRL Limited (a subsidiary of the Company) to the Company .Pursuant to the above , the Company has agreed to purchase the cumulative shareholding of Investors consisting of approx . 24.88 Lac equity shares aggregating to 3.1% of the equity share capital of SRL Limited at INR 423 per equity share. Post completion of the said acquisition , the equity shareholding of the Company in SRL Limited , shall increase to 57% from the existing shareholding of 53.9% , on a fully diluted basis.
- 24 Sep · Disclosure of Voting Pattern - Clause 35A
  Voting Results of the businesses transacted at the Annual General Meeting of the Shareholders of the Company, held on September 23, 2015 pursuant to Clause 35A of the Listing Agreement.
- 23 Sep · Meeting
  Outcome of the Annual General Meeting of the Company held on September 23, 2015..
- 23 Sep · Board meeting
  Board of Directors of the Company at its meeting held on September 23, 2015, considered and approved the following:(i) Structural re-arrangement of Kangra hospital, a unit/undertaking of the Company;(ii) Appointment of M/s. Jitender, Navneet & Co, as the Cost Auditors of the Company for the Financial Year 2015-16; and(iii) Re-designating Mr. Shivinder Mohan Singh from the position of Executive Vice Chairman to Non-Executive Vice Chairman of the Company w.e.f. January 1, 2016.Further the company has submitted a copy of Press release dated September 23, 2015 titled "Shivinder To Take Up Full-Time Sewa At Radha Soami Satsang Beas; Announces Transition To A Non Executive Role At Fortis".
- 16 Sep · Disclosure
  Nomination and Remuneration Committee of the Company has approved allotment of 56000 Equity Shares of Rs.10/- each, to the grantees, upon exercise of vested stock options. Consequent to the said allotment, the paid-up equity share capital of the Company stands increased to Rs. 4,629,407,940 /- divided into 462,940,794 equity shares of Rs.10/- each.
- 16 Sep · Legal
  Exchange had sought clarification from Fortis Healthcare Limited with respect to recent news item captioned "Fortis to exit pathology business in Dubai". The Company has clarified that "In continuance of its strategy to focus on India the Company/its subsidiaries are constantly evaluating various proposals with regard to its international assets. Towards our Dubai pathology business, currently held under one of our step down subsidiaries, we confirm that we have shown our interest in evaluating proposals, however, as on date, there is no firm proposal under consideration of the Management. We have updated the exchanges and public on all material developments in respect of any M&A transaction of this nature, as well as our India focused strategy as stated above and shall continue to update you, in case of any such development in the future as well".
- 16 Sep · Legal
  Exchange has sought clarification from Fortis Healthcare Limited with respect to recent news item captioned "Fortis to exit Pathology business in Dubai". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.
Aug 2015
Jul 2015
- 28 Jul · Board meeting
  To inter-alia, approve the Un-Audited Financial Results of the Company, for the Quarter ended June 30, 2015.
- 24 Jul · Management
  Mr. Bhavdeep Singh has been appointed as Chief Executive Officer of the Company with immediate effect.
Jun 2015
- 15 Jun · Business
  Nomination and Remuneration Committee of the Company has approved allotment of 1,000 Equity Shares of Rs.10/- each, to a grantee, upon exercise of vested stock options, under the "Employee Stock Option Plan 2007" of the Company. Consequent to the said allotment, the paid-up equity share capital of the Company stands increased to Rs. 4,628,847,940 /- divided into 462,884,794 equity shares of Rs.10/- each.
- 1 Jun · Disclosure
  Pursuant to Clause 25 of the Listing Agreement, Company would like to inform you that in terms of Employee Stock Option Scheme 2011 , the Nomination & Remuneration Committee of the Company has on June 01, 2015, approved granting of 1,00,000 (One lac) Stock Options, on the following terms: 1 No. of Shares covered : 1,00,000 Equity Shares. 2 Vesting Period : The options granted would vest at the end of three years from the date of Grant of such options. 3 Exercise Price : Rs. 175. 4 Maximum Exercise Period : The ESOPs granted are exercisable within a period of Four years from the date of vesting of the Employee Stock Options. The granting, vesting and exercise of the Options is subject to necessary regulatory and statutory approvals.
May 2015
- 28 May · Business
  Press release dated May 28, 2015, regarding Q4FY15 Results.

Fortis Healthcare share news and announcements

Aug 2016

Jul 2016

Jun 2016

May 2016

Mar 2016

Feb 2016

Jan 2016

Dec 2015

Nov 2015

Oct 2015

Sep 2015

Aug 2015

Jul 2015

Jun 2015

May 2015